Tevogen Bio Holdings Inc. (TVGN)

Tevogen Bio Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1.32	1.05	5.48	7.12
Cash & Cash Equivalents	1.32	1.05	5.48	7.12
Cash Growth	2420.70%	-80.81%	-22.96%	-
Receivables	0.16	0	0	0
Other Current Assets	0.92	0.67	0.35	0.05
Total Current Assets	2.4	1.72	5.84	7.17
Property, Plant & Equipment	0.83	0.93	1.31	0.14
Other Long-Term Assets	0.13	2.85	0.59	0.34
Total Long-Term Assets	0.96	3.78	1.9	0.49
Total Assets	3.36	5.51	7.74	7.66
Accounts Payable	5.46	3.42	0.87	0.38
Current Debt	1.91	80.96	0.28	0
Other Current Liabilities	1.56	1.1	0.82	0.29
Total Current Liabilities	8.94	85.48	1.96	0.67
Long-Term Debt	0.17	14.45	39.73	23.48
Other Long-Term Liabilities	0.06	0	0	0
Total Long-Term Liabilities	0.23	14.45	39.73	23.48
Total Liabilities	9.17	99.93	41.69	24.15
Total Debt	2.08	95.42	40.01	23.48
Debt Growth	-	138.50%	70.40%	-
Retained Earnings	-88.39	-99.66	-39.18	-17.14
Shareholders' Equity	-5.8	-94.43	-33.95	-16.49
Net Cash / Debt	-0.76	-94.37	-34.52	-16.36
Net Cash Per Share	-0.01	-3.81	-1.37	-0.65
Working Capital	-6.54	-83.76	3.88	6.51
Book Value Per Share	-0.04	-3.81	-1.34	-0.66

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).